| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,233 |
3,159 |
$309K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,440 |
4,359 |
$250K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,842 |
3,888 |
$152K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,955 |
1,931 |
$100K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
951 |
951 |
$79K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
831 |
831 |
$69K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
647 |
642 |
$50K |
| 90461 |
|
1,237 |
1,236 |
$46K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,628 |
1,606 |
$42K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
407 |
407 |
$37K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
3,739 |
3,731 |
$34K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
366 |
364 |
$27K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,963 |
1,962 |
$20K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
625 |
622 |
$19K |
| 96127 |
|
1,515 |
1,515 |
$16K |
| 99050 |
|
691 |
690 |
$11K |
| 90691 |
|
202 |
202 |
$11K |
| 99177 |
|
555 |
555 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,007 |
1,006 |
$7K |
| 0001A |
|
101 |
101 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
198 |
198 |
$4K |
| 36416 |
|
358 |
356 |
$4K |
| 0071A |
|
67 |
67 |
$3K |
| 0002A |
|
50 |
50 |
$2K |
| 94760 |
|
1,020 |
1,008 |
$2K |
| 0072A |
|
50 |
50 |
$2K |
| 99402 |
|
40 |
40 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
129 |
129 |
$2K |
| 83655 |
|
128 |
128 |
$2K |
| 80061 |
Lipid panel |
63 |
60 |
$764.03 |
| 0124A |
|
15 |
15 |
$688.20 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
28 |
28 |
$661.36 |
| 87081 |
|
96 |
96 |
$656.64 |
| 81003 |
|
258 |
255 |
$545.13 |
| 36415 |
Collection of venous blood by venipuncture |
169 |
167 |
$378.48 |
| 99173 |
|
16 |
16 |
$355.52 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$322.32 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$322.32 |
| 99000 |
|
140 |
139 |
$140.00 |